| Project/Area Number |
20791512
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Tottori University |
|---|
Principal Investigator |
KODANI Kazunori Tottori University, 医学部, 助教 (60403391)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | 口腔癌 / SCC / EZH2 / アテロコラーゲン / siRNA / SiRNA |
|---|
| Research Abstract |
We studied siRNA of EZH2 in tumor cells and, for confirmation of the antitumor effect, designed EZH2siRNA five kinds. The cancer cell used HSC-3,SCC-KN,HSC-4 and used Ateloarray○R (KOKEN) for cell culture.
As for sequence (GTGTATGAGTTTAGAGTCA) (#4) of EZH2 siRNA, mRNA inhibition and cell proliferation inhibition showed depression effect as compared with other sequence together. # 4 inhibits mRNA manifestation in high efficiency.
The reduction effect of the cancer was found when we injected it into the nude mouse which we mixed EZH2SiRNA with atelocollagen, and transplanted a cancer cell.
As a result, as for EZH2siRNA, antitumor effect was found in the oral cancer.
|
